CCIT: Launching & Funding Biotech University Start-Ups
Location: CCIT, 675 US Highway One, North Brunswick, New Jersey 08902
Featuring Leaders of Biotech Academic Spin-Offs in New Jersey
Thursday, June 15, 2017
5:00 pm - 7:00 pm
Biotech leaders/CCIT graduates will tell their story and provide guidance and recommendations on launching and funding their biotech academic spin-off.
Register now and join us at the CCIT Incubator, located at the Technology Centre of New Jersey, a 75 acre life sciences research park in the heart of N.J.'s Research Corridor, for networking and guidance from:
Christian Kopfli, CEO, Chromocell - Chromocell is a spin-off from Rockefeller University.
Michael Johnson, CEO, Visikol - Visikol is a spin-off from Rutgers University.
Benjamin Belinka, Ph.D. , Actinobac Biomed, Inc. - Actinobac is a spin-off from Rutgers University.
The panel will showcase biotech leaders on their respective paths to success, including insights into their strategy and decisions faced along the way to their companies becoming spinning out from a university.
675 US Highway One, North Brunswick, New Jersey 08902
NJEDA’s CCIT Life Sciences Incubator has partnered with Rutgers University to offer discounted space for academic spin-off companies. For eligible academic spin-offs, office space is available for as little as $333/month. Discounted lab space for academic spin-off companies is available at similar savings.
The CCIT life sciences incubator is located in a 75 acre research park owned by NJEDA. CCIT is almost 50K sf with 27 wet labs and access to offices, conference rooms, biotech training events, mentoring and a great biotech eco-system. The larger park itself is home to Chromocell, Allergan, Merial and Orthobond. For more information, contact Program Manager, Lenzie Harcum at email@example.com.